BioHealth News Archive
Major investments in Maryland’s life sciences sector
Investment in Maryland’s life sciences community is heating up only a few months into 2024. From new market launches to expanded production capabilities to…
Read More
TEDCO Invests in Baltimore Medical Device Company LASARRUS
COLUMBIA, Md. (April 1, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $50,000 Pre-Seed Builder Fund investment in LASARRUS, a…
Read More
Maryland Life Science Trend Analysis 2024
Venture financing for Maryland’s life sciences industry in 2023 shows signs of recovery following the significant downturn in 2022, with the total value of…
Read More
Baltimore’s LaunchPort Welcomes New Resident JuneBrain
LaunchPort welcomes CEO Samantha Scott and her team as the latest Residents to join the Baltimore Peninsula site. JuneBrain Inc. (https://www.junebrain.com/) offers accessible monitoring…
Read More
BioBuzz Networks and the International Society of Pharmaceutical Engineering – Chesapeake Bay Area Chapter Announce Exciting Partnership
March 28, 2024, Baltimore, MD. – BioBuzz Networks and the International Society of Pharmaceutical Engineering (ISPE) – Chesapeake Bay Area (CBA) Chapter are pleased to…
Read More
NIH cancer physician-scientist Christopher Hourigan joins Virginia Tech to lead research in Washington, D.C.
A globally recognized physician-scientist who studies and treats blood cancer is joining Virginia Tech to lead cancer research in Washington, D.C., said Michael Friedlander,…
Read More
Surviving and Thriving: John Sackett, Executive Vice President & COO of Adventist Healthcare, and a 67-Year-Old Cystic Fibrosis (CF) Survivor, Offers Perspectives on CF Life Science Innovation with Rich Bendis on BioTalk
ROCKVILLE, MARYLAND, April 1, 2024 - BioHealth Innovation, Inc. (BHI) is delighted to present a compelling episode on its podcast, BioTalk with Rich Bendis, titled…
Read More
MIMETAS to Participate in Holomicrobiome Institute, Backed by €200 Million from Dutch Cabinet
Amsterdam, March 15, 2024 – The government of the Netherlands has allocated €200 million from the country’s National Growth Fund for a public-private consortium that…
Read More
CNBC – Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage trial, a finding…
Read More
AMPEL BioSolutions’ Lupus Test Launches to Predict Flares & Drug Targets
CHARLOTTESVILLE, VA – March 26, 2024 – AMPEL BioSolutions announces a breakthrough in personalized precision medicine that will revolutionize the way doctors manage the autoimmune disease Lupus. Revealed…
Read More
WBJ: Germantown Precigen Inc. biotech expands manufacturing capacity, headcount ahead of potential product launch
Germantown’s Precigen Inc., a clinical-stage biotech developing gene and cell therapies for cancers and other diseases, is taking steps to get an experimental treatment…
Read More
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
Includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities AstraZeneca has entered into a definitive agreement to…
Read More
TEDCO Invests in Innate Technologies, Inc.
COLUMBIA, Md. (March 20, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 Maryland Equity Investment Fund (MEIF) investment in…
Read More
Clasp Therapeutics Launches With $150 Million to Pioneer Precision Immuno-Oncology Using Next-Generation T Cell Engagers With Unparalleled Specificity
CAMBRIDGE, Mass. & ROCKVILLE, Md.--(BUSINESS WIRE)--Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation T cell engagers (TCEs), launched today with…
Read More
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
CEL-4000 may deliver safe and effective therapy for RA by rebalancing the inflammatory response, without weakening important immune defense mechanisms, risking infections or cancer,…
Read More